United States · FDA National Drug Code directory
cetirizine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-974_71411b7e-4fb8-4c33-b260-287128711d0a
- Product NDC
- 45802-974
- Form
- SOLUTION
- Composition / generic term
- cetirizine hydrochloride
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080415
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 5 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (45802-974-26) / 118 mL in 1 BOTTLE · 45802-974-26
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →